SARIN ARADHANA 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
SARIN ARADHANA
Chief Strategy & Business Off
Transactions
- Sale
Common Stock, par value $.0001 per share
2019-06-21$132.00/sh−578$76,296→ 30,201 total
Footnotes (1)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.